Topics
Glioblastoma | Treatment | Clinical trials | Vaccines
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Vaccines
Galanis E, Dooley KE, Keith
Anderson S, Kurokawa CB, Carrero XW, Uhm JH, Federspiel MJ,
Leontovich AA, Aderca I, Viker KB, Hammack JE, Marks RS, Robinson
SI, Johnson DR, Kaufmann TJ, Buckner JC, Lachance DH, Burns TC,
Giannini C, Raghunathan A, Iankov ID, Parney IF.
Carcinoembryonic
antigen-expressing oncolytic measles virus derivative in recurrent
glioblastoma: a phase 1 trial.
Nat
Commun. 2024 Jan
12;15(1):493. doi:
10.1038/s41467-023-43076-7. PMID:
38216554. Interventional
study. ˍ
Muragaki
Y, Ishikawa E, Tamura M, Kawamata T, Gosho M, Hashimoto K, Komori
T, Yokoo H, Matsutani M, Maebayashi K, Tanaka T, Yamaguchi S,
Kanamori M, Yamamoto T, Hanihara M, Arakawa Y, Sasayama T, Abe T,
Nakamura H, Mukasa A, Uzuka T, Nakajo K, Ohno T.
A
randomized, placebo-controlled phase III trial of an autologous,
formalin-fixed tumor vaccine for newly diagnosed glioblastoma:
trial protocol.
Jpn
J Clin Oncol. 2025 May 16:hyaf078. doi:
10.1093/jjco/hyaf078. PMID:
40377260. Interventional study protocol˰
ˍ